Question 1

Does Royce & Associates own ACH stock?

Accepted Answer

No. Royce & Associates exited its ACH (Accendra Health) position in Q2 2026. Its Q1 2026 13F listed 25,698 shares worth $58,591.

Question 2

How many shares of ACH does Royce & Associates own?

Accepted Answer

None since Q2 2026, when Royce & Associates exited the position. Its Q1 2026 13F listed 25,698 shares worth $58,591.

Question 3

What is Royce & Associates' ACH position worth?

Accepted Answer

Royce & Associates' ACH position was worth $58,591 in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Royce & Associates buying or selling ACH?

Accepted Answer

In Q2 2026, Royce & Associates exited its entire ACH position.

Question 5

When did Royce & Associates first buy ACH?

Accepted Answer

Royce & Associates already held ACH in its Q1 2019 13F, the earliest on record, and listed it in 22 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$3.42	0
2026-Q1	Decreased	25,698	-62.3%	$58,591	0.0%	$2.28	0
2025-Q4	Decreased	68,149	-22.1%	$190,817	0.0%	$2.80	0
2025-Q3	Decreased	87,494	-8.7%	$419,971	0.0%	$4.80	0
2025-Q2	Increased	95,774	+6.5%	$871,543	0.0%	$9.10	27
2025-Q1	Unchanged	89,922	0.0%	$811,996	0.0%	$9.03	0
2024-Q4	Increased	89,922	+11.1%	$1.2M	0.0%	$13.07	28
2024-Q3	Increased	80,914	+179.4%	$1.3M	0.0%	$15.69	41